NK-LGL LEUKEMIA
Clinical trials for NK-LGL LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new NK-LGL LEUKEMIA trials appear
Sign up with your email to follow new studies for NK-LGL LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Old drug, new hope? thalidomide trial targets rare leukemia
Disease control Recruiting nowThis study tests if thalidomide alone can help people with a rare blood cancer called large granular lymphocytic (LGL) leukemia. About 48 adults with symptoms will take thalidomide pills for up to 3 months. If it doesn't work well enough, another drug (methotrexate) may be added.…
Matched conditions: NK-LGL LEUKEMIA
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 26, 2026 09:19 UTC
-
New hope for rare blood cancers: targeted drug shows promise
Disease control Recruiting nowThis study tests a drug called golidocitnib in people with certain slow-growing but incurable blood cancers (T/NK-cell lymphomas) that have not responded to standard treatment. About 48 adults will receive the drug to see if it shrinks tumors and how safe it is. The goal is to co…
Matched conditions: NK-LGL LEUKEMIA
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
Massive new registry tracks 8,000 blood cancer patients for decades
Knowledge-focused Recruiting nowThis study is a long-term registry that follows up to 8,000 people with chronic lymphocytic leukemia (CLL) and similar blood cancers. It does not test any new treatment but instead collects information on survival and disease course over many years. Participants must be 18 or old…
Matched conditions: NK-LGL LEUKEMIA
Sponsor: German CLL Study Group • Aim: Knowledge-focused
Last updated May 12, 2026 13:39 UTC